
Molina Healthcare MOH
$ 123.03
-1.85%
Annual report 2025
added 02-10-2026
Country |
|
IPO year |
2003 |
Industry |
Health care |
Stock Exchange |
NYSESPB |
Shares |
52.8 M |
Market Cap[1] |
$ 6.5 B |
EBITDA (LTM) |
$ 1.61 B |
P/E (LTM) |
7.27 |
P/S (LTM) |
0.16 |
EPS (LTM) |
17.4 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 288.12 | 0.11 % | $ 78.9 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 75.41 | -0.3 % | $ 95.5 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
Humana
HUM
|
$ 173.8 | -4.11 % | $ 21 B | NYSE,SPB | ||
|
Centene Corporation
CNC
|
$ 39.76 | 0.38 % | $ 20.7 B | NYSE,SPB | ||
|
NovoCure Limited
NVCR
|
$ 10.4 | -0.67 % | $ 1.12 B | Nasdaq Global Select Market,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 277.99 | 1.77 % | $ 256 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.